NOVAREX Co.Ltd (KQ:194700) — Market Cap & Net Worth
Market Cap & Net Worth: NOVAREX Co.Ltd (194700)
NOVAREX Co.Ltd (KQ:194700) has a market capitalization of $163.99 Million (₩241.99 Billion) as of June 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17400 globally and #710 in its home market, demonstrating a -5.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NOVAREX Co.Ltd's stock price ₩13670.00 by its total outstanding shares 17702216 (17.70 Million). Review NOVAREX Co.Ltd (194700) total liabilities to assess the company's total debt and financial obligations.
NOVAREX Co.Ltd Market Cap History: 2018 to 2026
NOVAREX Co.Ltd's market capitalization history from 2018 to 2026. Data shows growth from $88.35 Million to $163.99 Million (5.32% CAGR).
Index Memberships
NOVAREX Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$270.08 Billion | 0.06% | #267 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$270.08 Billion | 0.06% | #267 of 1384 |
Weight: NOVAREX Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NOVAREX Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NOVAREX Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NOVAREX Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
NOVAREX Co.Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $88.35 Million | $107.31 Billion | $9.49 Billion | 0.00x | 0.01x |
| 2019 | $113.17 Million | $159.10 Billion | $14.71 Billion | 0.00x | 0.01x |
| 2020 | $221.04 Million | $222.83 Billion | $25.15 Billion | 0.00x | 0.01x |
| 2021 | $220.00 Million | $278.79 Billion | $26.40 Billion | 0.00x | 0.01x |
| 2022 | $120.27 Million | $281.68 Billion | $19.99 Billion | 0.00x | 0.01x |
| 2023 | $145.64 Million | $302.17 Billion | $22.04 Billion | 0.00x | 0.01x |
| 2024 | $89.97 Million | $297.73 Billion | $23.02 Billion | 0.00x | 0.00x |
| 2025 | $167.95 Million | $404.26 Billion | $35.42 Billion | 0.00x | 0.00x |
Competitor Companies of 194700 by Market Capitalization
Companies near NOVAREX Co.Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to NOVAREX Co.Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #97 globally with a market cap of $204.31 Billion USD ( CHF161.60 Billion CHF).
- Danone SA (PA:BN): Ranked #550 globally with a market cap of $49.46 Billion USD ( €42.31 Billion EUR).
- Danone SA (F:BSND): Ranked #705 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €85.40 |
| #97 | Nestle S.A. | SW:NESN | $204.31 Billion | CHF78.96 |
| #550 | Danone SA | PA:BN | $49.46 Billion | €65.70 |
| #705 | Danone SA | F:BSND | $39.05 Billion | €12.80 |
NOVAREX Co.Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, NOVAREX Co.Ltd's market cap moved from $88.35 Million to $ 163.99 Million, with a yearly change of 5.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩163.99 Million | -2.36% |
| 2025 | ₩167.95 Million | +86.67% |
| 2024 | ₩89.97 Million | -38.22% |
| 2023 | ₩145.64 Million | +21.10% |
| 2022 | ₩120.27 Million | -45.33% |
| 2021 | ₩220.00 Million | -0.47% |
| 2020 | ₩221.04 Million | +95.31% |
| 2019 | ₩113.17 Million | +28.10% |
| 2018 | ₩88.35 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of NOVAREX Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $163.99 Million USD |
| MoneyControl | $163.99 Million USD |
| MarketWatch | $163.99 Million USD |
| marketcap.company | $163.99 Million USD |
| Reuters | $163.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more